RELATING TO THE UNIFORM CONTROLLED SUBSTANCE ACT.

Added 107 new synthetic opioids including fentanyl analogs like acrylfentanyl, butyrylfentanyl, and xylorphan to the controlled substances list.

Added 69 new hallucinogenic substances including novel psychoactive substances like 2C-T-7, methoxetamine, and various NBOMe compounds.

Added 14 new stimulants including substituted cathinones (bath salts) and novel compounds like eutylone and zipeprol.

Reorganized Schedule IV to include new depressants like daridorexant, lemborexant, and zuranolone while removing fenfluramine.

Reorganized Schedule IV stimulants section to include new medications like serdexmethylphenidate and solriamfetol while removing fenfluramine.

Updated the definition of opiates to include broader chemical structures and isomers of new synthetic compounds.

Added new precursor chemical restrictions for chemicals used to manufacture fentanyl and other controlled substances.

Set effective date to July 1, 3000, which appears to be a placeholder or error that should be corrected to a reasonable future date.

Added numerous new synthetic opioids and fentanyl analogs to Schedule II, including compounds like 3-methylfentanyl, 3-methylthiofentanyl, and various fluoro-substituted fentanyl variants.

Added new hallucinogenic substances to Schedule I, including various new psychoactive substances, synthetic cathinones, and specific analogs of existing controlled substances.

Added new stimulants to Schedule IV, including substituted cathinones and other compounds with stimulant effects on the central nervous system.

Updated the definition of opiates in Section 1(b) to include additional chemical compounds and clarify the scope of covered substances.

Added immediate precursors to fentanyl and other controlled substances to the list of substances regulated under the immediate precursor provisions.

Set the effective date for these changes to July 1, 3000, which appears to be a placeholder or error date that may need correction.

Added 111 new opioid substances including various fentanyl analogs (like acryl fentanyl, butyryl fentanyl, and numerous fluorinated variants) and other synthetic opioids to Schedule I.

Added 69 new hallucinogenic substances including novel psychoactive substances, synthetic cathinones, and designer drugs to Schedule I.

Added 15 new stimulant substances including substituted cathinones and novel amphetamine analogs to Schedule IV.

Added 60 new depressant substances to Schedule IV, including newer benzodiazepines and sleep medications.

Added fentanyl and its immediate precursors (ANPP and norfentanyl) to the list of controlled substances in Section 329-16.

Set the effective date of the new provisions to July 1, 2025.